Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
63°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Renovaro Inc. - Common Stock
(NQ:
RENB
)
0.2390
+0.0102 (+4.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Renovaro Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
August 19, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
August 08, 2025
Via
ACCESS Newswire
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
July 28, 2025
Via
ACCESS Newswire
Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
July 17, 2025
Via
ACCESS Newswire
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives
July 09, 2025
Via
ACCESS Newswire
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs
June 30, 2025
Via
ACCESS Newswire
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
June 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
May 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
May 14, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
May 13, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
April 22, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 09, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 04, 2025
From
Renovaro Inc
Via
GlobeNewswire
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB)
March 03, 2025
Via
Get News
Topics
Artificial Intelligence
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
March 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
March 03, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Announces $15 million in Equity Committed
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson
January 06, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 06, 2025
From
Renovaro Inc
Via
GlobeNewswire
Predictive Oncology Announces Agreement to be Acquired by Renovaro
January 06, 2025
From
Predictive Oncology Inc.
Via
GlobeNewswire
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
December 23, 2024
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Regains Compliance with NASDAQ Listing Requirement
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Strategic Collaboration with Nebul to Employ NVIDIA Cutting Edge AI Tech with Established GEDi CUBE as a Paradigm Shift for Early Disease Detection: Renovaro, Inc. (Nasdaq: RENB)
December 20, 2024
Via
Get News
Topics
Artificial Intelligence
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Renovaro Issues Shareholder Letter and Provides Corporate Update
November 04, 2024
From
Renovaro Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
